M&A Deal Summary

VWR International Acquires Reliable Biopharmaceutical

On November 3, 2016, VWR International acquired medical products company Reliable Biopharmaceutical from Med Opportunity Partners and The Gladstone Companies

Acquisition Highlights
  • This is VWR International’s 12th transaction in the Medical Products sector.
  • This is VWR International’s 13th transaction in the United States.
  • This is VWR International’s 1st transaction in Missouri.

M&A Deal Summary
Date 2016-11-03
Target Reliable Biopharmaceutical
Sector Medical Products
Buyer(s) VWR International
Sellers(s) Med Opportunity Partners
The Gladstone Companies
Deal Type Add-on Acquisition

Target

Reliable Biopharmaceutical

St. Louis, Missouri, United States
Reliable Biopharmaceutical LLC is a manufacturer of small volume, high value advanced pharmaceutical and biochemical intermediates, primarily for the generic injectable pharmaceutical industry.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

VWR International

Radnor, Pennsylvania, United States
Category Company
Founded 1852
Sector Distribution
Employees9,300
Revenue 4.5B USD (2016)
DESCRIPTION

VWR International LLC is a distributor of products, services and solutions to laboratory and production facilities. VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries.

DEAL STATS #
Overall 47 of 50
Sector (Medical Products) 12 of 13
Type (Add-on Acquisition) 40 of 43
State (Missouri) 1 of 1
Country (United States) 13 of 14
Year (2016) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-03 Bioarray Therapeutics

Farmington, Connecticut, United States

Bioarray Therapeutics, Inc. is a producer of U.S. origin serum-based products for use in research and production, strengthens our support to cellular science customers.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-12 Seastar Chemicals

Sidney, British Columbia, Canada

Seastar Chemicals, Inc. is a manufacturer of high purity reagents used in the global research, laboratory and microelectronics industries.

Buy -

Seller(S) 2

SELLER

Med Opportunity Partners

Greenwich, Connecticut, United States

Investor Investor

Category Private Equity Firm
Founded 2006
Size Small
Type Sector Focused
DESCRIPTION

Med Opportunity Partners LLC is a specialist private equity firm focuses on the healthcare sector. The Firm targets companies proven, growth-oriented companies with strong market positions and experienced management. For growth investments, the Firm looks to commit $5 to $20 million. For LBOs, Med looks to commit $10 to $40 million per transaction. Target transactions are generally valued between $20 and $200 million. Specific areas of interest include medical devices, pharmaceuticals, medical technology and specialty health care services. Med Opportunity Partners LLC was formed in 2006 and is based in Greenwich, Connecticut.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Missouri) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-04-01 Pfanstiehl

Waukegan, Illinois, United States

Pfanstiehl, Inc. is a provider of specialized products and services for niche pharmaceutical and biotechnological applications. Pfanstiehl develops and manufactures high-purity, low-endotoxin sugars utilized as injectable excipients and for cell culture media and protein stabilization as well as high-potency active pharmaceutical ingredients (APIs), including cytotoxic actives. Pfanstiehl was founded in 1919 and is based in Waukegan, Illinois.

Buy -
SELLER

The Gladstone Companies

Investor Investor Investor Investor Investor

Category Lender
Founded 2001
PE ASSETS 2.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

The Gladstone Companies manages a series of publicly traded investment vehicles and looks to make debt and equity investments in US-based small to middle-market businesses. The Firm focuses on second lien debt, mezzanine debt, secured and unsecured subordinated loans, equity and real estate sale leasebacks. Target investments generally range from $5 to $30 million in companies with over $3 million in EBITDA. Target sectors include manufacturing, industrial products, business and government Services, media, communications, consumer products and services, healthcare services, transportation, specialty chemicals, and energy services. The Gladstone Companies was formed in 2001 and is based in McLean, Virginia.

DEAL STATS #
Overall 6 of 18
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 3 of 8
State (Missouri) 1 of 1
Country (United States) 6 of 18
Year (2016) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-09-06 Westland Technologies

Modesto, California, United States

Westland Technologies, Inc. designs and manufactures custom-molded rubber parts for vibration and sound dampening, sealing, signature management, thermal insulation, and shock absorption in a range of industrial and defense applications. WTI provides sole-source mission critical technology used on a majority of the U.S. Naval fleet worldwide, including submarines (Virginia Class, Ohio Class, and Los Angeles Class), surface ships (cruisers and destroyers), and aircraft carriers.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-01 Behrens Manufacturing

Winona, Minnesota, United States

Behrens Manufacturing is a manufacturer and distributor of galvanized and metalware products that are sold primarily in home improvement, automotive, and hardware stores. Products produced by the company include a variety of galvanized steel products such as pails, garbage cans, utility tubs, planters, and funnels as well as other products for the promotional and advertising premium markets. Behrens Manufacturing was founded in 1911 and is based in Winona, Minnesota.

Sell -
Mergr

Product

Company

Legal